Top Rheumatology Research Papers

Overall: This randomized phase 3 trial shows a large, clinically meaningful steroid-sparing remission benefit in relapsed polymyalgia rheumatica, with similar serious adverse-event rates but added infection, access, and treatment burdens.

Overall: This large synthesis addresses a common primary-care problem with meaningful pain and function outcomes, but risk of bias and limited certainty temper confidence in the specific exercise rankings and dose targets.

Overall: This robust observational study reports a moderate reduction in hard cardiovascular outcomes, but residual confounding, absent safety data, and practical barriers limit its ability to change practice independently.

Overall: A rigorous trial found a large improvement in composite SLE response, but specialist administration, safety concerns, and limited direct evidence for patient-centered outcomes constrain its impact on routine US primary care.

Overall: A rigorous systematic review demonstrates meaningful efficacy for several advanced rheumatoid arthritis therapies, but uncertain comparative safety and its specialist-centered decision point substantially limit its impact on US primary care.

Overall: This well-completed pragmatic randomized trial addresses a common primary care problem with meaningful outcomes and an easy intervention, but it found no clinically convincing advantage for stable supportive footwear.

Overall: This large nationwide cohort links gout to a modest increase in ischemic stroke among patients with AF, but observational treatment findings and absent absolute benefit and safety data limit immediate practice change.

Overall: Hydroxychloroquine was associated with fewer recurrences, hospitalizations, and corticosteroid requirements, but the small uncontrolled before-and-after design prevents confident attribution of these improvements to treatment.

Overall: Glucagon-like peptide-1 receptor agonist and lupus nephritis in systemic lupus erythematosus with type 2 diabetes shows potentially important associations, but residual confounding, absent absolute effects and safety data, and the specialized population limit immediate implications for US primary care.

Overall: Low-dose aspirin was associated with slightly fewer cardiovascular events in patients with newly diagnosed giant cell arteritis, but the small benefit was initially offset by major bleeding and cannot establish causality.